Hebei Changshan Biochemical Pharmaceutical Co., LTD – Trademark Portfolio

Entity Type: 03

Hebei Changshan Biochemical Pharmaceutical Co., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AOSIDA. The owner is based in Hebei Province.

No. 9, Fuqiang Road

Hebei Province , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AOSIDA
AOSIDA
Registered 2020

Trademark Classifications

Hebei Changshan Biochemical Pharmaceutical Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Hebei Changshan Biochemical Pharmaceutical Co., LTD have?

Hebei Changshan Biochemical Pharmaceutical Co., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Hebei Changshan Biochemical Pharmaceutical Co., LTD file in?

Hebei Changshan Biochemical Pharmaceutical Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hebei Changshan Biochemical Pharmaceutical Co., LTD's most well-known trademarks?

Hebei Changshan Biochemical Pharmaceutical Co., LTD's registered trademark portfolio includes well-known marks such as AOSIDA. These are among 1 currently registered trademark in the portfolio.

What is Hebei Changshan Biochemical Pharmaceutical Co., LTD's trademark registration success rate?

Hebei Changshan Biochemical Pharmaceutical Co., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.